We Explore Gene
Advances in medical genetics have redefined diagnostics practices all over the world. Genetic testing has made it feasible not only to diagnose and treat rare genetic syndromes but also to determine the risk for common diseases and optimize their prevention.
With this vision, PanGenomics, a molecular and genetic laboratory was founded in 2014. A N.A.B.L. accredited PanGenomics, a subsidiary of Sterling Accuris Diagnostics offers the opportunity to improve health outcomes with genetic testing and counselling.
Moreover, PanGenomics* has also been authorized by ICMR & Govt. of India to conduct COVID-19/ Corona Testing by RT –PCR Method.
PanGenomics facilitates the most up-to-date genetic testing options with extensive support from trained and certified medical geneticists and genetic counsellors. With in-depth genetic counselling, PanGenomics takes patient care to the next level in coordination with referring physicians, to meet the needs of the patients and their families.
*(Reg. no. PGIA001)
Mission: To bring genetic information into mainstream medical practice to improve the quality of healthcare for everyone
SCOPE OF SERVICES
We offer clinical genetic testing for over 300 different genetic conditions using various technologies including Karyotyping, Fluorescence in situ hybridization (FISH), Array Comparative Genomic Hybridization (aCGH), PCR, real-time PCR, Multiplex Ligation-dependent Probe Amplification (MLPA), repeat expansion analysis, Sanger sequencing and Next Generation Sequencing (NGS).
Genetic Testing Menu
- PanCyto : Testing for chromosomal abnormalities and microdeletion syndromes
- PanCardio : Testing for Arrythmia, Cardiomyopathy and Aortopathy panels
- PanNeuro : Testing for myopathy, epilepsy and muscular dystrophy panels
- PanOnco : Testing for breast, ovarian, endometrial, colorectal and skin cancer syndromes
- PanPrenatal: Testing for aneuploidies, carrier screening and prenatal array
- PanSyndrome: Testing for syndromes such as Fragile X, Duchenne Muscular Dystrophy, Thalassemia, etc.
- PanPatho : Testing for HIV, HBV, and HCV
PanGenomics offers technical consultation regarding testing and its interpretation to medical professionals. The process helps the medical professional to clearly understand the genetic test results, diagnosis and options for treatment. Counselling the patients can help assess risks and determine the most appropriate genetic testing options.
Contract Research Organizations (CRO): PanGenomics acts as a companion and helps Contract Research Organizations (CROs) to co-relate and determine the impact of genetics on the outcome of the trials. At times, it collaborates with CROs to develop a companion diagnostic.
Advanced Genetics Solutions: PanGenomics has developed a range of products to assess the risk of developing disease, facilitate diagnosis, predict disease progression and patient counselling.
The detention of the COVID-19 virus requires the most sensitive and reliable Reverse-Transcription Polymerase Chain Reaction or RT PCR method. It directly detects the presence of an antigen, rather than the presence of the body’s immune response, or antibodies. The method has been recommended by World Health Organization (WHO).
At PanGenomics, our molecular testing division has the capability and infrastructure to conduct RT PCR for the effective and precise detection of COVID-19.